Paper167679
Binary ethylenimine as an inactivant for foot-and-mouth disease virus and its application for vaccine production.
Bahnemann HG. Arch Virol, 1975. Cited by 184 papers, by iCite.
Cite this record
ConductScience Library. Binary ethylenimine as an inactivant for foot-and-mouth disease virus and its application for vaccine production. Papers, record 167679. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/167679
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Binary ethylenimine as an inactivant for foot-and-mouth disease virus and its application for vaccine production.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aphthovirus | Major topic |
| Aziridines | Major topic |
| Azirines | Major topic |
| Viral Vaccines | Major topic |
| Animals | |
| Antigens, Viral | |
| Bromides | |
| Cell Line | |
| Chlorine | |
| Complement Fixation Tests | |
| Cricetinae | |
| Cyclization | |
| Ethylamines | |
| Guinea Pigs | |
| Kidney | |
| Sodium Hydroxide |
Source PubMed
References9
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4318509 | [The inactivation of foot-and-mouth disease virus by ethylethyleneimine and the use of the inactivated virus in the preparation of vaccines]. | Zentralbl Bakteriol Orig | 1970 | https://conductscience.org/library/papers/4318509 | PubMed |
| 2 | 14344712 | [THE OXAZOLIDONE REACTION OF 2-CHLOROETHYL-SUBSTITUTED SECONDARY AMINES]. | Arzneimittelforschung | 1964 | https://conductscience.org/library/papers/14344712 | PubMed |
| 6 | 4356910 | Derivatives of aziridine as inactivants for foot-and-mouth disease virus vaccines. | Am J Vet Res | 1973 | https://conductscience.org/library/papers/4356910 | PubMed |
| 7 | 4357652 | Inactivation of foot-and-mouth disease virus with ethylenimine. | Appl Microbiol | 1973 | https://conductscience.org/library/papers/4357652 | PubMed |
| 9 | 4356372 | The inactivation of foot-and-mouth disease virus by ethylenimine and propylenimine. | Zentralbl Veterinarmed B | 1972 | https://conductscience.org/library/papers/4356372 | PubMed |
| 10 | 13641679 | Application of agar-gel diffusion analysis to a study of the antigenic structure of inactivated vaccines prepared from the virus of foot-and-mouth disease. | J Immunol | 1959 | https://conductscience.org/library/papers/13641679 | PubMed |
| 12 | 14066590 | THE USE OF ACETYLETHYLENEIMINE IN THE PRODUCTION OF INACTIVATED FOOT-AND-MOUTH DISEASE VACCINES. | J Hyg (Lond) | 1963 | https://conductscience.org/library/papers/14066590 | PubMed |
| 14 | 5257323 | Acetylethyleneimine in the preparation of inactivated food-and-mouth disease vaccines. | Proc Annu Meet U S Anim Health Assoc | 1967 | https://conductscience.org/library/papers/5257323 | PubMed |
| 15 | 4293089 | Some experiences with chemical inactivants of foot-and-mouth disease virus. | J Immunol | 1967 | https://conductscience.org/library/papers/4293089 | PubMed |
Cited by63
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 184 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42795632 | Novel Thermostabilizing Formulation for Enhanced Stability of Foot-and-Mouth Disease Virus During Storage and Environmental Stress. | Microorganisms | 2026 | https://conductscience.org/library/papers/42795632 | PubMed |
| 41893799 | Evaluation of an Effective Intradermal Foot-and-Mouth Disease Vaccine for Early Protection. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/41893799 | PubMed |
| 41753660 | Development and Validation of a Population Assay for the Seroprevalence of Lumpy Skin Disease. | Microorganisms | 2026 | https://conductscience.org/library/papers/41753660 | PubMed |
| 40693030 | Development of solid phase competitive enzyme-linked immunosorbent assay to detect foot-and-mouth disease virus A serotype specific antibodies based on immunoglobulin Y antibody. | Vet Res Forum | 2025 | https://conductscience.org/library/papers/40693030 | PubMed |
| 40005490 | Yeast Strains as Probiotic and Postbiotic Agents for the Agglutination of Enteric Pathogens: A Preventive Approach. | Pathogens | 2025 | https://conductscience.org/library/papers/40005490 | PubMed |
| 39852801 | A Model H5N2 Vaccine Strain for Dual Protection Against H5N1 and H9N2 Avian Influenza Viruses. | Vaccines (Basel) | 2024 | https://conductscience.org/library/papers/39852801 | PubMed |
| 39845058 | Levamisole, as a viral vaccine adjuvant, induces robust host defense through the modulation of innate and adaptive immune responses. | Front Microbiol | 2024 | https://conductscience.org/library/papers/39845058 | PubMed |
| 39832111 | Comparative evaluation of protective efficacy of experimental inactivated vaccines against haemorrhagic septicaemia. | Braz J Microbiol | 2025 | https://conductscience.org/library/papers/39832111 | PubMed |
| 39257459 | Effect of different inactivants and preservatives on the stability of 146S fraction of foot-and-mouth diseases virus. | Vet Res Forum | 2024 | https://conductscience.org/library/papers/39257459 | PubMed |
| 38922028 | Why Foot-and-Mouth Disease-Free with Vaccination Should Be Equivalent to Foot-and-Mouth Disease-Free without Vaccination. | Vet Sci | 2024 | https://conductscience.org/library/papers/38922028 | PubMed |
| 38510965 | Isoprinosine as a foot-and-mouth disease vaccine adjuvant elicits robust host defense against viral infection through immunomodulation. | Front Cell Infect Microbiol | 2024 | https://conductscience.org/library/papers/38510965 | PubMed |
| 38433834 | D-galacto-D-mannan-mediated Dectin-2 activation orchestrates potent cellular and humoral immunity as a viral vaccine adjuvant. | Front Immunol | 2024 | https://conductscience.org/library/papers/38433834 | PubMed |
| 38029108 | Inactivated vaccine with glycyrrhizic acid adjuvant elicits potent innate and adaptive immune responses against foot-and-mouth disease. | Front Microbiol | 2023 | https://conductscience.org/library/papers/38029108 | PubMed |
| 38006022 | Bestatin, A Pluripotent Immunomodulatory Small Molecule, Drives Robust and Long-Lasting Immune Responses as an Adjuvant in Viral Vaccines. | Vaccines (Basel) | 2023 | https://conductscience.org/library/papers/38006022 | PubMed |
| 37789354 | Safety and immunogenicity of inactivated Rift Valley Fever Smithburn viral vaccine in sheep. | Virol J | 2023 | https://conductscience.org/library/papers/37789354 | PubMed |
| 37375450 | Efficacy of Binary Ethylenimine in the Inactivation of Foot-and-Mouth Disease Virus for Vaccine Production in South Korea. | Pathogens | 2023 | https://conductscience.org/library/papers/37375450 | PubMed |
| 37334361 | Dectin-1 signaling coordinates innate and adaptive immunity for potent host defense against viral infection. | Front Immunol | 2023 | https://conductscience.org/library/papers/37334361 | PubMed |
| 37112726 | Immunogenicity and Protection against Foot-and-Mouth Disease Virus in Swine Intradermally Vaccinated with a Bivalent Vaccine of Foot-and-Mouth Disease Virus Type O and A. | Vaccines (Basel) | 2023 | https://conductscience.org/library/papers/37112726 | PubMed |
| 36051749 | Improved safety profile of inactivated Neethling strain of the Lumpy Skin Disease Vaccine. | Vaccine X | 2022 | https://conductscience.org/library/papers/36051749 | PubMed |
| 35764653 | The C3d-fused foot-and-mouth disease vaccine platform overcomes maternally-derived antibody interference by inducing a potent adaptive immunity. | NPJ Vaccines | 2022 | https://conductscience.org/library/papers/35764653 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/167679
GET https://conductscience.org/api/papers/v1/167679/cited_by?page=2